Gradient Dissent: Conversations on AI
Sean & Greg — Biology and ML for Drug Discovery
December 02, 2021
Sean McClain is the founder and CEO, and Gregory Hannum is the VP of AI Research at Absci, a biotech company that's using deep learning to expedite drug discovery and development.
Lukas, Sean, and Greg talk about why Absci started investing so heavily in
Stories from AI experts solving real-world problems
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast